- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
According to our latest study, the global Novel Drug Delivery Systems market size was valued at USD 25000 million in 2022 and is forecast to a readjusted size of USD 27990 million by 2029 with a CAGR of 1.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
This report is a detailed and comprehensive analysis for global Novel Drug Delivery Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Novel Drug Delivery Systems market size and forecasts, in consumption value ($ Million), 2018-2029
Global Novel Drug Delivery Systems market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Novel Drug Delivery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Novel Drug Delivery Systems market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Novel Drug Delivery Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Novel Drug Delivery Systems market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Teva, Roche, UCB (Union Chimique Belge) and Celgene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Novel Drug Delivery Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Market segment by Application
Hospitals & Clinic
Cancer Treatment Centers
Others
Market segment by players, this report covers
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Novel Drug Delivery Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Novel Drug Delivery Systems, with revenue, gross margin and global market share of Novel Drug Delivery Systems from 2018 to 2023.
Chapter 3, the Novel Drug Delivery Systems competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Novel Drug Delivery Systems market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Novel Drug Delivery Systems.
Chapter 13, to describe Novel Drug Delivery Systems research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Novel Drug Delivery Systems
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Novel Drug Delivery Systems by Type
1.3.1 Overview: Global Novel Drug Delivery Systems Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Novel Drug Delivery Systems Consumption Value Market Share by Type in 2022
1.3.3 Liposomes
1.3.4 PEGylated Proteins & Polypeptides
1.3.5 Polymer Nanoparticle
1.3.6 Protein–drug Conjugates
1.3.7 Others
1.4 Global Novel Drug Delivery Systems Market by Application
1.4.1 Overview: Global Novel Drug Delivery Systems Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals & Clinic
1.4.3 Cancer Treatment Centers
1.4.4 Others
1.5 Global Novel Drug Delivery Systems Market Size & Forecast
1.6 Global Novel Drug Delivery Systems Market Size and Forecast by Region
1.6.1 Global Novel Drug Delivery Systems Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Novel Drug Delivery Systems Market Size by Region, (2018-2029)
1.6.3 North America Novel Drug Delivery Systems Market Size and Prospect (2018-2029)
1.6.4 Europe Novel Drug Delivery Systems Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Novel Drug Delivery Systems Market Size and Prospect (2018-2029)
1.6.6 South America Novel Drug Delivery Systems Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Novel Drug Delivery Systems Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Novel Drug Delivery Systems Product and Solutions
2.1.4 Amgen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Novel Drug Delivery Systems Product and Solutions
2.2.4 Teva Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Novel Drug Delivery Systems Product and Solutions
2.3.4 Roche Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments and Future Plans
2.4 UCB (Union Chimique Belge)
2.4.1 UCB (Union Chimique Belge) Details
2.4.2 UCB (Union Chimique Belge) Major Business
2.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product and Solutions
2.4.4 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 UCB (Union Chimique Belge) Recent Developments and Future Plans
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene Novel Drug Delivery Systems Product and Solutions
2.5.4 Celgene Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Celgene Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Novel Drug Delivery Systems Product and Solutions
2.6.4 Merck Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Recent Developments and Future Plans
2.7 Gilead Sciences
2.7.1 Gilead Sciences Details
2.7.2 Gilead Sciences Major Business
2.7.3 Gilead Sciences Novel Drug Delivery Systems Product and Solutions
2.7.4 Gilead Sciences Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Gilead Sciences Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Novel Drug Delivery Systems Product and Solutions
2.8.4 Sanofi Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Novel Drug Delivery Systems Product and Solutions
2.9.4 Pfizer Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Novel Drug Delivery Systems Product and Solutions
2.10.4 Takeda Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Takeda Recent Developments and Future Plans
2.11 Bausch&Lomb
2.11.1 Bausch&Lomb Details
2.11.2 Bausch&Lomb Major Business
2.11.3 Bausch&Lomb Novel Drug Delivery Systems Product and Solutions
2.11.4 Bausch&Lomb Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bausch&Lomb Recent Developments and Future Plans
2.12 Samyang Biopharmaceuticals
2.12.1 Samyang Biopharmaceuticals Details
2.12.2 Samyang Biopharmaceuticals Major Business
2.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product and Solutions
2.12.4 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Samyang Biopharmaceuticals Recent Developments and Future Plans
2.13 Johnson & Johnson
2.13.1 Johnson & Johnson Details
2.13.2 Johnson & Johnson Major Business
2.13.3 Johnson & Johnson Novel Drug Delivery Systems Product and Solutions
2.13.4 Johnson & Johnson Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Johnson & Johnson Recent Developments and Future Plans
2.14 TOLMAR
2.14.1 TOLMAR Details
2.14.2 TOLMAR Major Business
2.14.3 TOLMAR Novel Drug Delivery Systems Product and Solutions
2.14.4 TOLMAR Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 TOLMAR Recent Developments and Future Plans
2.15 Astellas
2.15.1 Astellas Details
2.15.2 Astellas Major Business
2.15.3 Astellas Novel Drug Delivery Systems Product and Solutions
2.15.4 Astellas Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Astellas Recent Developments and Future Plans
2.16 AMAG Pharmaceuticals
2.16.1 AMAG Pharmaceuticals Details
2.16.2 AMAG Pharmaceuticals Major Business
2.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Product and Solutions
2.16.4 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 AMAG Pharmaceuticals Recent Developments and Future Plans
2.17 AbbVie
2.17.1 AbbVie Details
2.17.2 AbbVie Major Business
2.17.3 AbbVie Novel Drug Delivery Systems Product and Solutions
2.17.4 AbbVie Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 AbbVie Recent Developments and Future Plans
2.18 Dr Reddy
2.18.1 Dr Reddy Details
2.18.2 Dr Reddy Major Business
2.18.3 Dr Reddy Novel Drug Delivery Systems Product and Solutions
2.18.4 Dr Reddy Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Dr Reddy Recent Developments and Future Plans
2.19 AstraZeneca
2.19.1 AstraZeneca Details
2.19.2 AstraZeneca Major Business
2.19.3 AstraZeneca Novel Drug Delivery Systems Product and Solutions
2.19.4 AstraZeneca Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 AstraZeneca Recent Developments and Future Plans
2.20 Aspen
2.20.1 Aspen Details
2.20.2 Aspen Major Business
2.20.3 Aspen Novel Drug Delivery Systems Product and Solutions
2.20.4 Aspen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Aspen Recent Developments and Future Plans
2.21 Acrotech Biopharma
2.21.1 Acrotech Biopharma Details
2.21.2 Acrotech Biopharma Major Business
2.21.3 Acrotech Biopharma Novel Drug Delivery Systems Product and Solutions
2.21.4 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Acrotech Biopharma Recent Developments and Future Plans
2.22 TWi Pharmaceuticals
2.22.1 TWi Pharmaceuticals Details
2.22.2 TWi Pharmaceuticals Major Business
2.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Product and Solutions
2.22.4 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 TWi Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Novel Drug Delivery Systems Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Novel Drug Delivery Systems by Company Revenue
3.2.2 Top 3 Novel Drug Delivery Systems Players Market Share in 2022
3.2.3 Top 6 Novel Drug Delivery Systems Players Market Share in 2022
3.3 Novel Drug Delivery Systems Market: Overall Company Footprint Analysis
3.3.1 Novel Drug Delivery Systems Market: Region Footprint
3.3.2 Novel Drug Delivery Systems Market: Company Product Type Footprint
3.3.3 Novel Drug Delivery Systems Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Novel Drug Delivery Systems Consumption Value and Market Share by Type (2018-2023)
4.2 Global Novel Drug Delivery Systems Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Novel Drug Delivery Systems Consumption Value Market Share by Application (2018-2023)
5.2 Global Novel Drug Delivery Systems Market Forecast by Application (2024-2029)
6 North America
6.1 North America Novel Drug Delivery Systems Consumption Value by Type (2018-2029)
6.2 North America Novel Drug Delivery Systems Consumption Value by Application (2018-2029)
6.3 North America Novel Drug Delivery Systems Market Size by Country
6.3.1 North America Novel Drug Delivery Systems Consumption Value by Country (2018-2029)
6.3.2 United States Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
6.3.3 Canada Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
6.3.4 Mexico Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Novel Drug Delivery Systems Consumption Value by Type (2018-2029)
7.2 Europe Novel Drug Delivery Systems Consumption Value by Application (2018-2029)
7.3 Europe Novel Drug Delivery Systems Market Size by Country
7.3.1 Europe Novel Drug Delivery Systems Consumption Value by Country (2018-2029)
7.3.2 Germany Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
7.3.3 France Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
7.3.5 Russia Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
7.3.6 Italy Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Novel Drug Delivery Systems Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Novel Drug Delivery Systems Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Novel Drug Delivery Systems Market Size by Region
8.3.1 Asia-Pacific Novel Drug Delivery Systems Consumption Value by Region (2018-2029)
8.3.2 China Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
8.3.3 Japan Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
8.3.4 South Korea Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
8.3.5 India Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
8.3.7 Australia Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
9 South America
9.1 South America Novel Drug Delivery Systems Consumption Value by Type (2018-2029)
9.2 South America Novel Drug Delivery Systems Consumption Value by Application (2018-2029)
9.3 South America Novel Drug Delivery Systems Market Size by Country
9.3.1 South America Novel Drug Delivery Systems Consumption Value by Country (2018-2029)
9.3.2 Brazil Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
9.3.3 Argentina Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Novel Drug Delivery Systems Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Novel Drug Delivery Systems Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Country
10.3.1 Middle East & Africa Novel Drug Delivery Systems Consumption Value by Country (2018-2029)
10.3.2 Turkey Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
10.3.4 UAE Novel Drug Delivery Systems Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Novel Drug Delivery Systems Market Drivers
11.2 Novel Drug Delivery Systems Market Restraints
11.3 Novel Drug Delivery Systems Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Novel Drug Delivery Systems Industry Chain
12.2 Novel Drug Delivery Systems Upstream Analysis
12.3 Novel Drug Delivery Systems Midstream Analysis
12.4 Novel Drug Delivery Systems Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Novel Drug Delivery Systems Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Novel Drug Delivery Systems Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Novel Drug Delivery Systems Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Novel Drug Delivery Systems Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Novel Drug Delivery Systems Product and Solutions
Table 8. Amgen Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Amgen Recent Developments and Future Plans
Table 10. Teva Company Information, Head Office, and Major Competitors
Table 11. Teva Major Business
Table 12. Teva Novel Drug Delivery Systems Product and Solutions
Table 13. Teva Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Teva Recent Developments and Future Plans
Table 15. Roche Company Information, Head Office, and Major Competitors
Table 16. Roche Major Business
Table 17. Roche Novel Drug Delivery Systems Product and Solutions
Table 18. Roche Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Roche Recent Developments and Future Plans
Table 20. UCB (Union Chimique Belge) Company Information, Head Office, and Major Competitors
Table 21. UCB (Union Chimique Belge) Major Business
Table 22. UCB (Union Chimique Belge) Novel Drug Delivery Systems Product and Solutions
Table 23. UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. UCB (Union Chimique Belge) Recent Developments and Future Plans
Table 25. Celgene Company Information, Head Office, and Major Competitors
Table 26. Celgene Major Business
Table 27. Celgene Novel Drug Delivery Systems Product and Solutions
Table 28. Celgene Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Celgene Recent Developments and Future Plans
Table 30. Merck Company Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Novel Drug Delivery Systems Product and Solutions
Table 33. Merck Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Merck Recent Developments and Future Plans
Table 35. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 36. Gilead Sciences Major Business
Table 37. Gilead Sciences Novel Drug Delivery Systems Product and Solutions
Table 38. Gilead Sciences Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Gilead Sciences Recent Developments and Future Plans
Table 40. Sanofi Company Information, Head Office, and Major Competitors
Table 41. Sanofi Major Business
Table 42. Sanofi Novel Drug Delivery Systems Product and Solutions
Table 43. Sanofi Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Sanofi Recent Developments and Future Plans
Table 45. Pfizer Company Information, Head Office, and Major Competitors
Table 46. Pfizer Major Business
Table 47. Pfizer Novel Drug Delivery Systems Product and Solutions
Table 48. Pfizer Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Pfizer Recent Developments and Future Plans
Table 50. Takeda Company Information, Head Office, and Major Competitors
Table 51. Takeda Major Business
Table 52. Takeda Novel Drug Delivery Systems Product and Solutions
Table 53. Takeda Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Takeda Recent Developments and Future Plans
Table 55. Bausch&Lomb Company Information, Head Office, and Major Competitors
Table 56. Bausch&Lomb Major Business
Table 57. Bausch&Lomb Novel Drug Delivery Systems Product and Solutions
Table 58. Bausch&Lomb Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Bausch&Lomb Recent Developments and Future Plans
Table 60. Samyang Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Samyang Biopharmaceuticals Major Business
Table 62. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product and Solutions
Table 63. Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Samyang Biopharmaceuticals Recent Developments and Future Plans
Table 65. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 66. Johnson & Johnson Major Business
Table 67. Johnson & Johnson Novel Drug Delivery Systems Product and Solutions
Table 68. Johnson & Johnson Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Johnson & Johnson Recent Developments and Future Plans
Table 70. TOLMAR Company Information, Head Office, and Major Competitors
Table 71. TOLMAR Major Business
Table 72. TOLMAR Novel Drug Delivery Systems Product and Solutions
Table 73. TOLMAR Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. TOLMAR Recent Developments and Future Plans
Table 75. Astellas Company Information, Head Office, and Major Competitors
Table 76. Astellas Major Business
Table 77. Astellas Novel Drug Delivery Systems Product and Solutions
Table 78. Astellas Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Astellas Recent Developments and Future Plans
Table 80. AMAG Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 81. AMAG Pharmaceuticals Major Business
Table 82. AMAG Pharmaceuticals Novel Drug Delivery Systems Product and Solutions
Table 83. AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. AMAG Pharmaceuticals Recent Developments and Future Plans
Table 85. AbbVie Company Information, Head Office, and Major Competitors
Table 86. AbbVie Major Business
Table 87. AbbVie Novel Drug Delivery Systems Product and Solutions
Table 88. AbbVie Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AbbVie Recent Developments and Future Plans
Table 90. Dr Reddy Company Information, Head Office, and Major Competitors
Table 91. Dr Reddy Major Business
Table 92. Dr Reddy Novel Drug Delivery Systems Product and Solutions
Table 93. Dr Reddy Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Dr Reddy Recent Developments and Future Plans
Table 95. AstraZeneca Company Information, Head Office, and Major Competitors
Table 96. AstraZeneca Major Business
Table 97. AstraZeneca Novel Drug Delivery Systems Product and Solutions
Table 98. AstraZeneca Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. AstraZeneca Recent Developments and Future Plans
Table 100. Aspen Company Information, Head Office, and Major Competitors
Table 101. Aspen Major Business
Table 102. Aspen Novel Drug Delivery Systems Product and Solutions
Table 103. Aspen Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Aspen Recent Developments and Future Plans
Table 105. Acrotech Biopharma Company Information, Head Office, and Major Competitors
Table 106. Acrotech Biopharma Major Business
Table 107. Acrotech Biopharma Novel Drug Delivery Systems Product and Solutions
Table 108. Acrotech Biopharma Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Acrotech Biopharma Recent Developments and Future Plans
Table 110. TWi Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 111. TWi Pharmaceuticals Major Business
Table 112. TWi Pharmaceuticals Novel Drug Delivery Systems Product and Solutions
Table 113. TWi Pharmaceuticals Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. TWi Pharmaceuticals Recent Developments and Future Plans
Table 115. Global Novel Drug Delivery Systems Revenue (USD Million) by Players (2018-2023)
Table 116. Global Novel Drug Delivery Systems Revenue Share by Players (2018-2023)
Table 117. Breakdown of Novel Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Novel Drug Delivery Systems, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 119. Head Office of Key Novel Drug Delivery Systems Players
Table 120. Novel Drug Delivery Systems Market: Company Product Type Footprint
Table 121. Novel Drug Delivery Systems Market: Company Product Application Footprint
Table 122. Novel Drug Delivery Systems New Market Entrants and Barriers to Market Entry
Table 123. Novel Drug Delivery Systems Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Novel Drug Delivery Systems Consumption Value (USD Million) by Type (2018-2023)
Table 125. Global Novel Drug Delivery Systems Consumption Value Share by Type (2018-2023)
Table 126. Global Novel Drug Delivery Systems Consumption Value Forecast by Type (2024-2029)
Table 127. Global Novel Drug Delivery Systems Consumption Value by Application (2018-2023)
Table 128. Global Novel Drug Delivery Systems Consumption Value Forecast by Application (2024-2029)
Table 129. North America Novel Drug Delivery Systems Consumption Value by Type (2018-2023) & (USD Million)
Table 130. North America Novel Drug Delivery Systems Consumption Value by Type (2024-2029) & (USD Million)
Table 131. North America Novel Drug Delivery Systems Consumption Value by Application (2018-2023) & (USD Million)
Table 132. North America Novel Drug Delivery Systems Consumption Value by Application (2024-2029) & (USD Million)
Table 133. North America Novel Drug Delivery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 134. North America Novel Drug Delivery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 135. Europe Novel Drug Delivery Systems Consumption Value by Type (2018-2023) & (USD Million)
Table 136. Europe Novel Drug Delivery Systems Consumption Value by Type (2024-2029) & (USD Million)
Table 137. Europe Novel Drug Delivery Systems Consumption Value by Application (2018-2023) & (USD Million)
Table 138. Europe Novel Drug Delivery Systems Consumption Value by Application (2024-2029) & (USD Million)
Table 139. Europe Novel Drug Delivery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Novel Drug Delivery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Novel Drug Delivery Systems Consumption Value by Type (2018-2023) & (USD Million)
Table 142. Asia-Pacific Novel Drug Delivery Systems Consumption Value by Type (2024-2029) & (USD Million)
Table 143. Asia-Pacific Novel Drug Delivery Systems Consumption Value by Application (2018-2023) & (USD Million)
Table 144. Asia-Pacific Novel Drug Delivery Systems Consumption Value by Application (2024-2029) & (USD Million)
Table 145. Asia-Pacific Novel Drug Delivery Systems Consumption Value by Region (2018-2023) & (USD Million)
Table 146. Asia-Pacific Novel Drug Delivery Systems Consumption Value by Region (2024-2029) & (USD Million)
Table 147. South America Novel Drug Delivery Systems Consumption Value by Type (2018-2023) & (USD Million)
Table 148. South America Novel Drug Delivery Systems Consumption Value by Type (2024-2029) & (USD Million)
Table 149. South America Novel Drug Delivery Systems Consumption Value by Application (2018-2023) & (USD Million)
Table 150. South America Novel Drug Delivery Systems Consumption Value by Application (2024-2029) & (USD Million)
Table 151. South America Novel Drug Delivery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 152. South America Novel Drug Delivery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 153. Middle East & Africa Novel Drug Delivery Systems Consumption Value by Type (2018-2023) & (USD Million)
Table 154. Middle East & Africa Novel Drug Delivery Systems Consumption Value by Type (2024-2029) & (USD Million)
Table 155. Middle East & Africa Novel Drug Delivery Systems Consumption Value by Application (2018-2023) & (USD Million)
Table 156. Middle East & Africa Novel Drug Delivery Systems Consumption Value by Application (2024-2029) & (USD Million)
Table 157. Middle East & Africa Novel Drug Delivery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 158. Middle East & Africa Novel Drug Delivery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 159. Novel Drug Delivery Systems Raw Material
Table 160. Key Suppliers of Novel Drug Delivery Systems Raw Materials
List of Figures
Figure 1. Novel Drug Delivery Systems Picture
Figure 2. Global Novel Drug Delivery Systems Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Novel Drug Delivery Systems Consumption Value Market Share by Type in 2022
Figure 4. Liposomes
Figure 5. PEGylated Proteins & Polypeptides
Figure 6. Polymer Nanoparticle
Figure 7. Protein–drug Conjugates
Figure 8. Others
Figure 9. Global Novel Drug Delivery Systems Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Novel Drug Delivery Systems Consumption Value Market Share by Application in 2022
Figure 11. Hospitals & Clinic Picture
Figure 12. Cancer Treatment Centers Picture
Figure 13. Others Picture
Figure 14. Global Novel Drug Delivery Systems Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Novel Drug Delivery Systems Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Novel Drug Delivery Systems Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Novel Drug Delivery Systems Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Novel Drug Delivery Systems Consumption Value Market Share by Region in 2022
Figure 19. North America Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Novel Drug Delivery Systems Revenue Share by Players in 2022
Figure 25. Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Novel Drug Delivery Systems Market Share in 2022
Figure 27. Global Top 6 Players Novel Drug Delivery Systems Market Share in 2022
Figure 28. Global Novel Drug Delivery Systems Consumption Value Share by Type (2018-2023)
Figure 29. Global Novel Drug Delivery Systems Market Share Forecast by Type (2024-2029)
Figure 30. Global Novel Drug Delivery Systems Consumption Value Share by Application (2018-2023)
Figure 31. Global Novel Drug Delivery Systems Market Share Forecast by Application (2024-2029)
Figure 32. North America Novel Drug Delivery Systems Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Novel Drug Delivery Systems Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Novel Drug Delivery Systems Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Novel Drug Delivery Systems Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Novel Drug Delivery Systems Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Novel Drug Delivery Systems Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 42. France Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Novel Drug Delivery Systems Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Novel Drug Delivery Systems Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Novel Drug Delivery Systems Consumption Value Market Share by Region (2018-2029)
Figure 49. China Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 52. India Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Novel Drug Delivery Systems Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Novel Drug Delivery Systems Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Novel Drug Delivery Systems Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Novel Drug Delivery Systems Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Novel Drug Delivery Systems Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Novel Drug Delivery Systems Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Novel Drug Delivery Systems Consumption Value (2018-2029) & (USD Million)
Figure 66. Novel Drug Delivery Systems Market Drivers
Figure 67. Novel Drug Delivery Systems Market Restraints
Figure 68. Novel Drug Delivery Systems Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Novel Drug Delivery Systems in 2022
Figure 71. Manufacturing Process Analysis of Novel Drug Delivery Systems
Figure 72. Novel Drug Delivery Systems Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
